Semler Scientific soars 31% as company reveals Bitcoin investment 📈

5:00 PM 28 May 2024

Medical technology and supplies company Semler Scientific (SMLR.US) revealed that has bought 581 BTC for about $40 million. Following this announcement, its shares rose by more than 31%. The company indicated that Bitcoin has been gaining tremendous popularity in recent months, after SEC greenlight January 11 and will prove to be a hedge against rising inflation or global instability in the future. Semler decided to invest its cash surpluses precisely in BTC, and the company's CEO Eric Semler stressed that the strategy of allocating capital surpluses in BTC will be maintained in the long term.

  • At the same time, the company is focused on maintaining sales of QuantaFlo and is awaiting approval from the FDA for additional use of its proprietary technology, in cardiovascular diagnostics and treatment. Given the company's capitalization of $212 million, we can expect that its shares may prove sensitive to future price fluctuations and Bitcoin volatility. Microstrategy's CEO, Michael Saylor blissfully relayed the company's statement via the X platform.
  • Semler Scientific has no debt and remains a profitable company, although the market's recent concern has been a problem with sustained revenue growth and slightly lower margins. Also, Bitcoin investment may be a signal that a company didn't recognize a more effective way of capital allocation and may have a problem with scaling its core business.

Semler Scientific (SMLR.US) shares, H1 interval

Source: xStation5

Start investing today or test a free demo

Open real account TRY DEMO Download mobile app Download mobile app
Xtb logo

Join over 1 000 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits

We use cookies

By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

This group contains cookies that are necessary for our websites to work. They take part in functionalities like language preferences, traffic distribution or keeping user session. They cannot be disabled.

Cookie name
userBranchSymbol cc 2 March 2024
test_cookie cc 25 January 2024
adobe_unique_id cc 1 March 2025
__hssc cc 8 September 2022
SESSID cc 2 March 2024
__cf_bm cc 8 September 2022
intercom-id-iojaybix cc 26 November 2024
intercom-session-iojaybix cc 8 March 2024

We use tools that let us analyze the usage of our page. Such data lets us improve the user experience of our web service.

Cookie name
_gid cc 9 September 2022
_gat_UA-98728395-1 cc 8 September 2022
_gat_UA-121192761-1 cc 8 September 2022
_gcl_au cc 30 May 2024
_ga_CBPL72L2EC cc 1 March 2026
_ga cc 1 March 2026
__hstc cc 7 March 2023

This group of cookies is used to show you ads of topics that you are interested in. It also lets us monitor our marketing activities, it helps to measure the performance of our ads.

Cookie name
MUID cc 26 March 2025
_omappvp cc 11 February 2035
_omappvs cc 1 March 2024
_uetsid cc 2 March 2024
_uetvid cc 26 March 2025
_fbp cc 30 May 2024
fr cc 7 December 2022
_ttp cc 26 March 2025
_tt_enable_cookie cc 26 March 2025
_ttp cc 26 March 2025
hubspotutk cc 7 March 2023

Cookies from this group store your preferences you gave while using the site, so that they will already be here when you visit the page after some time.

Cookie name

This page uses cookies. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. For more information see our Privacy Policy You can manage cookies by clicking "Settings". If you agree to our use of cookies, click "Accept all".

Change region and language
Country of residence